0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Phage Therapy Kits Market Research Report 2026
Published Date: 2026-04-20
|
Report Code: QYRE-Auto-37Z16946
Home | Market Reports | Science| Biological Sciences
Global Phage Therapy Kits Market Research Report 2024
BUY CHAPTERS

Global Phage Therapy Kits Market Research Report 2026

Code: QYRE-Auto-37Z16946
Report
2026-04-20
Pages:119
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Phage Therapy Kits Market Size

The global Phage Therapy Kits market was valued at US$ 47.76 million in 2025 and is anticipated to reach US$ 130 million by 2032, at a CAGR of 15.6% from 2026 to 2032.

Phage Therapy Kits Market

Phage Therapy Kits Market

The 2025 U.S. tariff policies introduce profound uncertainty into the global economic landscape. This report critically examines the implications of recent tariff adjustments and international strategic countermeasures on Phage Therapy Kits competitive dynamics, regional economic interdependencies, and supply chain reconfigurations.
Phage Therapy Kits refer to the use of bacteriophages, which are viruses that target and destroy specific bacterial strains, for the treatment of bacterial infections. These kits typically contain a selection of phages that can be used to treat infections that are resistant to antibiotics.
Phage therapy, the therapeutic use of bacteriophages (viruses that infect bacteria), is a promising field with significant potential to address the growing challenge of antibiotic resistance. As such, the market for phage therapy kits is expected to experience substantial growth in the coming years.
Here are some key trends that are likely to shape the future market for phage therapy kits:
1. Increasing Prevalence of Antibiotic Resistance:
Rising antibiotic resistance: The overuse and misuse of antibiotics have led to a global increase in antibiotic-resistant bacteria, making traditional treatments less effective. This will drive demand for alternative solutions like phage therapy.
Expanded applications: Phage therapy is being explored for a wide range of infections, including skin infections, urinary tract infections, and respiratory infections. As research progresses and clinical trials demonstrate efficacy, the market for phage therapy kits will expand.
2. Advancements in Phage Research and Development:
Improved phage identification and characterization: Technological advancements will enable faster and more accurate identification and characterization of phages, leading to the development of more targeted and effective phage therapy kits.
Enhanced phage engineering: Researchers are exploring ways to engineer phages to improve their therapeutic properties, such as increasing their stability, broadening their host range, and enhancing their ability to overcome bacterial defenses.
3. Growing Regulatory Acceptance:
Regulatory approvals: As regulatory bodies gain more experience with phage therapy, we can expect to see an increase in approvals for phage therapy products. This will provide greater market access and boost investor confidence.
International collaboration: Global cooperation and harmonization of regulatory frameworks will facilitate the development and commercialization of phage therapy kits across different regions.
4. Increased Investment and Industry Interest:
Venture capital and pharmaceutical investments: The potential of phage therapy to address the antibiotic resistance crisis has attracted significant investment from venture capital firms and pharmaceutical companies. This increased interest will drive innovation and accelerate the development of phage therapy kits.
Partnerships and collaborations: Strategic partnerships between academic institutions, research organizations, and biotechnology companies will foster collaboration and accelerate the translation of phage therapy research into commercial products.
5. Personalized Phage Therapy:
Tailored phage cocktails: Advancements in genomics and personalized medicine will enable the development of customized phage cocktails that are specifically tailored to individual patients and their unique infections.
Precision phage therapy: This approach will improve treatment outcomes and reduce the risk of adverse effects.
Overall, the future market for phage therapy kits is poised for significant growth driven by the increasing prevalence of antibiotic resistance, advancements in phage research, regulatory acceptance, increased investment, and the potential for personalized phage therapy. As the field continues to evolve, we can expect to see a wider range of phage therapy products becoming available to patients, offering new hope for the treatment of antibiotic-resistant infections.
This report delivers a comprehensive overview of the global Phage Therapy Kits market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Phage Therapy Kits. The Phage Therapy Kits market size, estimates, and forecasts are provided in terms of sales volume (K Units) and revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2021–2032.
The report segments the global Phage Therapy Kits market comprehensively. Regional market sizes by Type, by Application, , and by company are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.
This report will assist Phage Therapy Kits manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.
Market Segmentation

Scope of Phage Therapy Kits Market Report

Report Metric Details
Report Name Phage Therapy Kits Market
Accounted market size in 2025 US$ 47.76 million
Forecasted market size in 2032 US$ 130 million
CAGR 15.6%
Base Year 2025
Forecasted years 2026 - 2032
Segment by Type
  • Medical Grade
  • Laboratory Grade
by Application
  • Medical
  • Food Industry
  • Agriculture
  • Others
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company BiomX, PhagePro, PhagoMed Biopharma, MYRIADE, DotBio, Wuhan Greinon Biotechnology, PhagePharm, iNtRON Biotechnology, Snipr Technologies, CJ, Phico Therapeutics
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, , etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
  • Chapter 2: Provides a detailed analysis of the competitive landscape for Phage Therapy Kits manufacturers, covering pricing, sales and revenue shares, latest development plans, and mergers and acquisitions.
  • Chapter 3: Examines Phage Therapy Kits sales and revenue at the regional and country levels. It quantifies market size and growth potential for each region and its key countries, and outlines market development, outlook, addressable space, and national market size.
  • Chapter 4: Analyzes segments by Type, detailing the size and growth potential of each segment to help readers identify “blue ocean” opportunities.
  • Chapter 5: Analyzes market segments by Application, covering the size and growth potential of each segment to help readers identify “blue ocean” opportunities in downstream markets.
  • Chapter 6: Profiles key players, presenting core information on leading companies, including product sales, revenue, pricing, gross margin, product portfolio/introductions, and recent developments.
  • Chapter 7: Reviews the industry value chain, including upstream and downstream segments.
  • Chapter 8: Discusses market dynamics and recent developments, including drivers, restraints, challenges and risks for manufacturers, U.S. Tariffs and relevant policy analysis.
  • Chapter 9: Summarizes the key findings and conclusions of the report.

FAQ for this report

How fast is Phage Therapy Kits Market growing?

Ans: The Phage Therapy Kits Market witnessing a CAGR of 15.6% during the forecast period 2026-2032.

What is the Phage Therapy Kits Market size in 2032?

Ans: The Phage Therapy Kits Market size in 2032 will be US$ 130 million.

Who are the main players in the Phage Therapy Kits Market report?

Ans: The main players in the Phage Therapy Kits Market are BiomX, PhagePro, PhagoMed Biopharma, MYRIADE, DotBio, Wuhan Greinon Biotechnology, PhagePharm, iNtRON Biotechnology, Snipr Technologies, CJ, Phico Therapeutics

What are the Application segmentation covered in the Phage Therapy Kits Market report?

Ans: The Applications covered in the Phage Therapy Kits Market report are Medical, Food Industry, Agriculture, Others

What are the Type segmentation covered in the Phage Therapy Kits Market report?

Ans: The Types covered in the Phage Therapy Kits Market report are Medical Grade, Laboratory Grade

1 Phage Therapy Kits Market Overview
1.1 Product Definition
1.2 Phage Therapy Kits by Type
1.2.1 Global Phage Therapy Kits Market Value by Type: 2025 vs 2032
1.2.2 Medical Grade
1.2.3 Laboratory Grade
1.3 Phage Therapy Kits by Application
1.3.1 Global Phage Therapy Kits Market Value by Application: 2025 vs 2032
1.3.2 Medical
1.3.3 Food Industry
1.3.4 Agriculture
1.3.5 Others
1.4 Global Phage Therapy Kits Market Size Estimates and Forecasts
1.4.1 Global Phage Therapy Kits Revenue 2021–2032
1.4.2 Global Phage Therapy Kits Sales 2021–2032
1.4.3 Global Phage Therapy Kits Market Average Price (2021–2032)
1.5 Assumptions and Limitations
2 Phage Therapy Kits Market Competition by Manufacturers
2.1 Global Phage Therapy Kits Sales Market Share by Manufacturers (2021–2026)
2.2 Global Phage Therapy Kits Revenue Market Share by Manufacturers (2021–2026)
2.3 Global Phage Therapy Kits Average Price by Manufacturers (2021–2026)
2.4 Global Key Players of Phage Therapy Kits, Industry Ranking, 2023 vs 2024 vs 2025
2.5 Global Key Manufacturers of Phage Therapy Kits, Manufacturing Sites and Headquarters
2.6 Global Key Manufacturers of Phage Therapy Kits, Product Types and Applications
2.7 Global Key Manufacturers of Phage Therapy Kits, Date of Entry into the Industry
2.8 Global Phage Therapy Kits Market Competitive Situation and Trends
2.8.1 Global Phage Therapy Kits Market Concentration Rate
2.8.2 The Top 5 and Top 10 Global Phage Therapy Kits Players Market Share by Revenue
2.8.3 Global Phage Therapy Kits Market Share by Company Tier (Tier 1, Tier 2, Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Phage Therapy Kits Market Scenario by Region
3.1 Global Phage Therapy Kits Market Size by Region: 2021 vs 2025 vs 2032
3.2 Global Phage Therapy Kits Sales by Region: 2021–2032
3.2.1 Global Phage Therapy Kits Sales by Region: 2021–2026
3.2.2 Global Phage Therapy Kits Sales by Region: 2027–2032
3.3 Global Phage Therapy Kits Revenue by Region: 2021–2032
3.3.1 Global Phage Therapy Kits Revenue by Region: 2021–2026
3.3.2 Global Phage Therapy Kits Revenue by Region: 2027–2032
3.4 North America Phage Therapy Kits Market Facts & Figures by Country
3.4.1 North America Phage Therapy Kits Market Size by Country: 2021 vs 2025 vs 2032
3.4.2 North America Phage Therapy Kits Sales by Country (2021–2032)
3.4.3 North America Phage Therapy Kits Revenue by Country (2021–2032)
3.4.4 United States
3.4.5 Canada
3.5 Europe Phage Therapy Kits Market Facts & Figures by Country
3.5.1 Europe Phage Therapy Kits Market Size by Country: 2021 vs 2025 vs 2032
3.5.2 Europe Phage Therapy Kits Sales by Country (2021–2032)
3.5.3 Europe Phage Therapy Kits Revenue by Country (2021–2032)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Phage Therapy Kits Market Facts & Figures by Region
3.6.1 Asia Pacific Phage Therapy Kits Market Size by Region: 2021 vs 2025 vs 2032
3.6.2 Asia Pacific Phage Therapy Kits Sales by Region (2021–2032)
3.6.3 Asia Pacific Phage Therapy Kits Revenue by Region (2021–2032)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Phage Therapy Kits Market Facts & Figures by Country
3.7.1 Latin America Phage Therapy Kits Market Size by Country: 2021 vs 2025 vs 2032
3.7.2 Latin America Phage Therapy Kits Sales by Country (2021–2032)
3.7.3 Latin America Phage Therapy Kits Revenue by Country (2021–2032)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.7.7 Colombia
3.8 Middle East and Africa Phage Therapy Kits Market Facts & Figures by Country
3.8.1 Middle East and Africa Phage Therapy Kits Market Size by Country: 2021 vs 2025 vs 2032
3.8.2 Middle East and Africa Phage Therapy Kits Sales by Country (2021–2032)
3.8.3 Middle East and Africa Phage Therapy Kits Revenue by Country (2021–2032)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Phage Therapy Kits Sales by Type (2021–2032)
4.1.1 Global Phage Therapy Kits Sales by Type (2021–2026)
4.1.2 Global Phage Therapy Kits Sales by Type (2027–2032)
4.1.3 Global Phage Therapy Kits Sales Market Share by Type (2021–2032)
4.2 Global Phage Therapy Kits Revenue by Type (2021–2032)
4.2.1 Global Phage Therapy Kits Revenue by Type (2021–2026)
4.2.2 Global Phage Therapy Kits Revenue by Type (2027–2032)
4.2.3 Global Phage Therapy Kits Revenue Market Share by Type (2021–2032)
4.3 Global Phage Therapy Kits Price by Type (2021–2032)
5 Segment by Application
5.1 Global Phage Therapy Kits Sales by Application (2021–2032)
5.1.1 Global Phage Therapy Kits Sales by Application (2021–2026)
5.1.2 Global Phage Therapy Kits Sales by Application (2027–2032)
5.1.3 Global Phage Therapy Kits Sales Market Share by Application (2021–2032)
5.2 Global Phage Therapy Kits Revenue by Application (2021–2032)
5.2.1 Global Phage Therapy Kits Revenue by Application (2021–2026)
5.2.2 Global Phage Therapy Kits Revenue by Application (2027–2032)
5.2.3 Global Phage Therapy Kits Revenue Market Share by Application (2021–2032)
5.3 Global Phage Therapy Kits Price by Application (2021–2032)
6 Key Companies Profiled
6.1 BiomX
6.1.1 BiomX Company Information
6.1.2 BiomX Description and Business Overview
6.1.3 BiomX Phage Therapy Kits Sales, Revenue, and Gross Margin (2021–2026)
6.1.4 BiomX Phage Therapy Kits Product Portfolio
6.1.5 BiomX Recent Developments/Updates
6.2 PhagePro
6.2.1 PhagePro Company Information
6.2.2 PhagePro Description and Business Overview
6.2.3 PhagePro Phage Therapy Kits Sales, Revenue, and Gross Margin (2021–2026)
6.2.4 PhagePro Phage Therapy Kits Product Portfolio
6.2.5 PhagePro Recent Developments/Updates
6.3 PhagoMed Biopharma
6.3.1 PhagoMed Biopharma Company Information
6.3.2 PhagoMed Biopharma Description and Business Overview
6.3.3 PhagoMed Biopharma Phage Therapy Kits Sales, Revenue, and Gross Margin (2021–2026)
6.3.4 PhagoMed Biopharma Phage Therapy Kits Product Portfolio
6.3.5 PhagoMed Biopharma Recent Developments/Updates
6.4 MYRIADE
6.4.1 MYRIADE Company Information
6.4.2 MYRIADE Description and Business Overview
6.4.3 MYRIADE Phage Therapy Kits Sales, Revenue, and Gross Margin (2021–2026)
6.4.4 MYRIADE Phage Therapy Kits Product Portfolio
6.4.5 MYRIADE Recent Developments/Updates
6.5 DotBio
6.5.1 DotBio Company Information
6.5.2 DotBio Description and Business Overview
6.5.3 DotBio Phage Therapy Kits Sales, Revenue, and Gross Margin (2021–2026)
6.5.4 DotBio Phage Therapy Kits Product Portfolio
6.5.5 DotBio Recent Developments/Updates
6.6 Wuhan Greinon Biotechnology
6.6.1 Wuhan Greinon Biotechnology Company Information
6.6.2 Wuhan Greinon Biotechnology Description and Business Overview
6.6.3 Wuhan Greinon Biotechnology Phage Therapy Kits Sales, Revenue, and Gross Margin (2021–2026)
6.6.4 Wuhan Greinon Biotechnology Phage Therapy Kits Product Portfolio
6.6.5 Wuhan Greinon Biotechnology Recent Developments/Updates
6.7 PhagePharm
6.7.1 PhagePharm Company Information
6.7.2 PhagePharm Description and Business Overview
6.7.3 PhagePharm Phage Therapy Kits Sales, Revenue, and Gross Margin (2021–2026)
6.7.4 PhagePharm Phage Therapy Kits Product Portfolio
6.7.5 PhagePharm Recent Developments/Updates
6.8 iNtRON Biotechnology
6.8.1 iNtRON Biotechnology Company Information
6.8.2 iNtRON Biotechnology Description and Business Overview
6.8.3 iNtRON Biotechnology Phage Therapy Kits Sales, Revenue, and Gross Margin (2021–2026)
6.8.4 iNtRON Biotechnology Phage Therapy Kits Product Portfolio
6.8.5 iNtRON Biotechnology Recent Developments/Updates
6.9 Snipr Technologies
6.9.1 Snipr Technologies Company Information
6.9.2 Snipr Technologies Description and Business Overview
6.9.3 Snipr Technologies Phage Therapy Kits Sales, Revenue, and Gross Margin (2021–2026)
6.9.4 Snipr Technologies Phage Therapy Kits Product Portfolio
6.9.5 Snipr Technologies Recent Developments/Updates
6.10 CJ
6.10.1 CJ Company Information
6.10.2 CJ Description and Business Overview
6.10.3 CJ Phage Therapy Kits Sales, Revenue, and Gross Margin (2021–2026)
6.10.4 CJ Phage Therapy Kits Product Portfolio
6.10.5 CJ Recent Developments/Updates
6.11 Phico Therapeutics
6.11.1 Phico Therapeutics Company Information
6.11.2 Phico Therapeutics Description and Business Overview
6.11.3 Phico Therapeutics Phage Therapy Kits Sales, Revenue, and Gross Margin (2021–2026)
6.11.4 Phico Therapeutics Phage Therapy Kits Product Portfolio
6.11.5 Phico Therapeutics Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Phage Therapy Kits Industry Chain Analysis
7.2 Phage Therapy Kits Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Phage Therapy Kits Production Mode & Process Analysis
7.4 Phage Therapy Kits Sales and Marketing
7.4.1 Phage Therapy Kits Sales Channels
7.4.2 Phage Therapy Kits Distributors
7.5 Phage Therapy Kits Customer Analysis
8 Phage Therapy Kits Market Dynamics
8.1 Phage Therapy Kits Industry Trends
8.2 Phage Therapy Kits Market Drivers
8.3 Phage Therapy Kits Market Challenges
8.4 Phage Therapy Kits Market Restraints
8.5 Impact of U.S. Tariffs
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Tables
 Table 1. Global Phage Therapy Kits Market Value by Type (US$ Million), 2025 vs 2032
 Table 2. Global Phage Therapy Kits Market Value by Application (US$ Million), 2025 vs 2032
 Table 3. Global Phage Therapy Kits Market Competitive Situation by Manufacturers in 2025
 Table 4. Global Phage Therapy Kits Sales (K Units) of Key Manufacturers (2021–2026)
 Table 5. Global Phage Therapy Kits Sales Market Share by Manufacturers (2021–2026)
 Table 6. Global Phage Therapy Kits Revenue (US$ Million) by Manufacturers (2021–2026)
 Table 7. Global Phage Therapy Kits Revenue Share by Manufacturers (2021–2026)
 Table 8. Global Market Phage Therapy Kits Average Price (US$/Unit) of Key Manufacturers (2021–2026)
 Table 9. Global Key Players of Phage Therapy Kits, Industry Ranking, 2023 vs 2024 vs 2025
 Table 10. Global Key Manufacturers of Phage Therapy Kits, Manufacturing Sites and Headquarters
 Table 11. Global Key Manufacturers of Phage Therapy Kits, Product Types and Applications
 Table 12. Global Key Manufacturers of Phage Therapy Kits, Date of Entry into the Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Phage Therapy Kits Companies by Tier (Tier 1, Tier 2, Tier 3), based on Phage Therapy Kits Revenue, 2025
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global Phage Therapy Kits Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
 Table 17. Global Phage Therapy Kits Sales by Region (K Units), 2021–2026
 Table 18. Global Phage Therapy Kits Sales Market Share by Region (2021–2026)
 Table 19. Global Phage Therapy Kits Sales by Region (K Units), 2027–2032
 Table 20. Global Phage Therapy Kits Sales Market Share by Region (2027–2032)
 Table 21. Global Phage Therapy Kits Revenue by Region (US$ Million), 2021–2026
 Table 22. Global Phage Therapy Kits Revenue Market Share by Region (2021–2026)
 Table 23. Global Phage Therapy Kits Revenue by Region (US$ Million), 2027–2032
 Table 24. Global Phage Therapy Kits Revenue Market Share by Region (2027–2032)
 Table 25. North America Phage Therapy Kits Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
 Table 26. North America Phage Therapy Kits Sales by Country (K Units), 2021–2026
 Table 27. North America Phage Therapy Kits Sales by Country (K Units), 2027–2032
 Table 28. North America Phage Therapy Kits Revenue by Country (US$ Million), 2021–2026
 Table 29. North America Phage Therapy Kits Revenue by Country (US$ Million), 2027–2032
 Table 30. Europe Phage Therapy Kits Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
 Table 31. Europe Phage Therapy Kits Sales by Country (K Units), 2021–2026
 Table 32. Europe Phage Therapy Kits Sales by Country (K Units), 2027–2032
 Table 33. Europe Phage Therapy Kits Revenue by Country (US$ Million), 2021–2026
 Table 34. Europe Phage Therapy Kits Revenue by Country (US$ Million), 2027–2032
 Table 35. Asia Pacific Phage Therapy Kits Revenue by Region: 2021 vs 2025 vs 2032 (US$ Million)
 Table 36. Asia Pacific Phage Therapy Kits Sales by Region (K Units), 2021–2026
 Table 37. Asia Pacific Phage Therapy Kits Sales by Region (K Units), 2027–2032
 Table 38. Asia Pacific Phage Therapy Kits Revenue by Region (US$ Million), 2021–2026
 Table 39. Asia Pacific Phage Therapy Kits Revenue by Region (US$ Million), 2027–2032
 Table 40. Latin America Phage Therapy Kits Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
 Table 41. Latin America Phage Therapy Kits Sales by Country (K Units), 2021–2026
 Table 42. Latin America Phage Therapy Kits Sales by Country (K Units), 2027–2032
 Table 43. Latin America Phage Therapy Kits Revenue by Country (US$ Million), 2021–2026
 Table 44. Latin America Phage Therapy Kits Revenue by Country (US$ Million), 2027–2032
 Table 45. Middle East and Africa Phage Therapy Kits Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
 Table 46. Middle East and Africa Phage Therapy Kits Sales by Country (K Units), 2021–2026
 Table 47. Middle East and Africa Phage Therapy Kits Sales by Country (K Units), 2027–2032
 Table 48. Middle East and Africa Phage Therapy Kits Revenue by Country (US$ Million), 2021–2026
 Table 49. Middle East and Africa Phage Therapy Kits Revenue by Country (US$ Million), 2027–2032
 Table 50. Global Phage Therapy Kits Sales (K Units) by Type (2021–2026)
 Table 51. Global Phage Therapy Kits Sales (K Units) by Type (2027–2032)
 Table 52. Global Phage Therapy Kits Sales Market Share by Type (2021–2026)
 Table 53. Global Phage Therapy Kits Sales Market Share by Type (2027–2032)
 Table 54. Global Phage Therapy Kits Revenue (US$ Million) by Type (2021–2026)
 Table 55. Global Phage Therapy Kits Revenue (US$ Million) by Type (2027–2032)
 Table 56. Global Phage Therapy Kits Revenue Market Share by Type (2021–2026)
 Table 57. Global Phage Therapy Kits Revenue Market Share by Type (2027–2032)
 Table 58. Global Phage Therapy Kits Price (US$/Unit) by Type (2021–2026)
 Table 59. Global Phage Therapy Kits Price (US$/Unit) by Type (2027–2032)
 Table 60. Global Phage Therapy Kits Sales (K Units) by Application (2021–2026)
 Table 61. Global Phage Therapy Kits Sales (K Units) by Application (2027–2032)
 Table 62. Global Phage Therapy Kits Sales Market Share by Application (2021–2026)
 Table 63. Global Phage Therapy Kits Sales Market Share by Application (2027–2032)
 Table 64. Global Phage Therapy Kits Revenue (US$ Million) by Application (2021–2026)
 Table 65. Global Phage Therapy Kits Revenue (US$ Million) by Application (2027–2032)
 Table 66. Global Phage Therapy Kits Revenue Market Share by Application (2021–2026)
 Table 67. Global Phage Therapy Kits Revenue Market Share by Application (2027–2032)
 Table 68. Global Phage Therapy Kits Price (US$/Unit) by Application (2021–2026)
 Table 69. Global Phage Therapy Kits Price (US$/Unit) by Application (2027–2032)
 Table 70. BiomX Company Information
 Table 71. BiomX Description and Business Overview
 Table 72. BiomX Phage Therapy Kits Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 73. BiomX Phage Therapy Kits Product
 Table 74. BiomX Recent Developments/Updates
 Table 75. PhagePro Company Information
 Table 76. PhagePro Description and Business Overview
 Table 77. PhagePro Phage Therapy Kits Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 78. PhagePro Phage Therapy Kits Product
 Table 79. PhagePro Recent Developments/Updates
 Table 80. PhagoMed Biopharma Company Information
 Table 81. PhagoMed Biopharma Description and Business Overview
 Table 82. PhagoMed Biopharma Phage Therapy Kits Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 83. PhagoMed Biopharma Phage Therapy Kits Product
 Table 84. PhagoMed Biopharma Recent Developments/Updates
 Table 85. MYRIADE Company Information
 Table 86. MYRIADE Description and Business Overview
 Table 87. MYRIADE Phage Therapy Kits Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 88. MYRIADE Phage Therapy Kits Product
 Table 89. MYRIADE Recent Developments/Updates
 Table 90. DotBio Company Information
 Table 91. DotBio Description and Business Overview
 Table 92. DotBio Phage Therapy Kits Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 93. DotBio Phage Therapy Kits Product
 Table 94. DotBio Recent Developments/Updates
 Table 95. Wuhan Greinon Biotechnology Company Information
 Table 96. Wuhan Greinon Biotechnology Description and Business Overview
 Table 97. Wuhan Greinon Biotechnology Phage Therapy Kits Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 98. Wuhan Greinon Biotechnology Phage Therapy Kits Product
 Table 99. Wuhan Greinon Biotechnology Recent Developments/Updates
 Table 100. PhagePharm Company Information
 Table 101. PhagePharm Description and Business Overview
 Table 102. PhagePharm Phage Therapy Kits Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 103. PhagePharm Phage Therapy Kits Product
 Table 104. PhagePharm Recent Developments/Updates
 Table 105. iNtRON Biotechnology Company Information
 Table 106. iNtRON Biotechnology Description and Business Overview
 Table 107. iNtRON Biotechnology Phage Therapy Kits Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 108. iNtRON Biotechnology Phage Therapy Kits Product
 Table 109. iNtRON Biotechnology Recent Developments/Updates
 Table 110. Snipr Technologies Company Information
 Table 111. Snipr Technologies Description and Business Overview
 Table 112. Snipr Technologies Phage Therapy Kits Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 113. Snipr Technologies Phage Therapy Kits Product
 Table 114. Snipr Technologies Recent Developments/Updates
 Table 115. CJ Company Information
 Table 116. CJ Description and Business Overview
 Table 117. CJ Phage Therapy Kits Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 118. CJ Phage Therapy Kits Product
 Table 119. CJ Recent Developments/Updates
 Table 120. Phico Therapeutics Company Information
 Table 121. Phico Therapeutics Description and Business Overview
 Table 122. Phico Therapeutics Phage Therapy Kits Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 123. Phico Therapeutics Phage Therapy Kits Product
 Table 124. Phico Therapeutics Recent Developments/Updates
 Table 125. Key Raw Materials Lists
 Table 126. Raw Materials Key Suppliers Lists
 Table 127. Phage Therapy Kits Distributors List
 Table 128. Phage Therapy Kits Customers List
 Table 129. Phage Therapy Kits Market Trends
 Table 130. Phage Therapy Kits Market Drivers
 Table 131. Phage Therapy Kits Market Challenges
 Table 132. Phage Therapy Kits Market Restraints
 Table 133. Research Programs/Design for This Report
 Table 134. Key Data Information from Secondary Sources
 Table 135. Key Data Information from Primary Sources
 Table 136. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Phage Therapy Kits
 Figure 2. Global Phage Therapy Kits Market Value by Type (US$ Million), 2021–2032
 Figure 3. Global Phage Therapy Kits Market Share by Type: 2025 & 2032
 Figure 4. Medical Grade Product Picture
 Figure 5. Laboratory Grade Product Picture
 Figure 6. Global Phage Therapy Kits Market Value by Application (US$ Million), 2021–2032
 Figure 7. Global Phage Therapy Kits Market Share by Application: 2025 & 2032
 Figure 8. Medical
 Figure 9. Food Industry
 Figure 10. Agriculture
 Figure 11. Others
 Figure 12. Global Phage Therapy Kits Revenue, (US$ Million), 2021 vs 2025 vs 2032
 Figure 13. Global Phage Therapy Kits Market Size (US$ Million), 2021–2032
 Figure 14. Global Phage Therapy Kits Sales (K Units), 2021–2032
 Figure 15. Global Phage Therapy Kits Average Price (US$/Unit), 2021–2032
 Figure 16. Phage Therapy Kits Report Years Considered
 Figure 17. Phage Therapy Kits Sales Share by Manufacturers in 2025
 Figure 18. Global Phage Therapy Kits Revenue Share by Manufacturers in 2025
 Figure 19. Top 5 and Top 10 Global Phage Therapy Kits Players: Market Share by Revenue in Phage Therapy Kits in 2025
 Figure 20. Phage Therapy Kits Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2021 vs 2025
 Figure 21. Global Phage Therapy Kits Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
 Figure 22. North America Phage Therapy Kits Sales Market Share by Country (2021–2032)
 Figure 23. North America Phage Therapy Kits Revenue Market Share by Country (2021–2032)
 Figure 24. United States Phage Therapy Kits Revenue Growth Rate (US$ Million), 2021–2032
 Figure 25. Canada Phage Therapy Kits Revenue Growth Rate (US$ Million), 2021–2032
 Figure 26. Europe Phage Therapy Kits Sales Market Share by Country (2021–2032)
 Figure 27. Europe Phage Therapy Kits Revenue Market Share by Country (2021–2032)
 Figure 28. Germany Phage Therapy Kits Revenue Growth Rate (US$ Million), 2021–2032
 Figure 29. France Phage Therapy Kits Revenue Growth Rate (US$ Million), 2021–2032
 Figure 30. U.K. Phage Therapy Kits Revenue Growth Rate (US$ Million), 2021–2032
 Figure 31. Italy Phage Therapy Kits Revenue Growth Rate (US$ Million), 2021–2032
 Figure 32. Russia Phage Therapy Kits Revenue Growth Rate (US$ Million), 2021–2032
 Figure 33. Asia Pacific Phage Therapy Kits Sales Market Share by Region (2021–2032)
 Figure 34. Asia Pacific Phage Therapy Kits Revenue Market Share by Region (2021–2032)
 Figure 35. China Phage Therapy Kits Revenue Growth Rate (US$ Million), 2021–2032
 Figure 36. Japan Phage Therapy Kits Revenue Growth Rate (US$ Million), 2021–2032
 Figure 37. South Korea Phage Therapy Kits Revenue Growth Rate (US$ Million), 2021–2032
 Figure 38. India Phage Therapy Kits Revenue Growth Rate (US$ Million), 2021–2032
 Figure 39. Australia Phage Therapy Kits Revenue Growth Rate (US$ Million), 2021–2032
 Figure 40. China Taiwan Phage Therapy Kits Revenue Growth Rate (US$ Million), 2021–2032
 Figure 41. Southeast Asia Phage Therapy Kits Revenue Growth Rate (US$ Million), 2021–2032
 Figure 42. Latin America Phage Therapy Kits Sales Market Share by Country (2021–2032)
 Figure 43. Latin America Phage Therapy Kits Revenue Market Share by Country (2021–2032)
 Figure 44. Mexico Phage Therapy Kits Revenue Growth Rate (US$ Million), 2021–2032
 Figure 45. Brazil Phage Therapy Kits Revenue Growth Rate (US$ Million), 2021–2032
 Figure 46. Argentina Phage Therapy Kits Revenue Growth Rate (US$ Million), 2021–2032
 Figure 47. Colombia Phage Therapy Kits Revenue Growth Rate (US$ Million), 2021–2032
 Figure 48. Middle East and Africa Phage Therapy Kits Sales Market Share by Country (2021–2032)
 Figure 49. Middle East and Africa Phage Therapy Kits Revenue Market Share by Country (2021–2032)
 Figure 50. Turkey Phage Therapy Kits Revenue Growth Rate (US$ Million), 2021–2032
 Figure 51. Saudi Arabia Phage Therapy Kits Revenue Growth Rate (US$ Million), 2021–2032
 Figure 52. UAE Phage Therapy Kits Revenue Growth Rate (US$ Million), 2021–2032
 Figure 53. Global Sales Market Share of Phage Therapy Kits by Type (2021–2032)
 Figure 54. Global Revenue Market Share of Phage Therapy Kits by Type (2021–2032)
 Figure 55. Global Phage Therapy Kits Price (US$/Unit) by Type (2021–2032)
 Figure 56. Global Sales Market Share of Phage Therapy Kits by Application (2021–2032)
 Figure 57. Global Revenue Market Share of Phage Therapy Kits by Application (2021–2032)
 Figure 58. Global Phage Therapy Kits Price (US$/Unit) by Application (2021–2032)
 Figure 59. Phage Therapy Kits Value Chain
 Figure 60. Channels of Distribution (Direct Vs Distribution)
 Figure 61. Bottom-up and Top-down Approaches for This Report
 Figure 62. Data Triangulation
 Figure 63. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic

$2900

Single User License
Electronic

$4350

Multi User License
Electronic

$5800

Enterprise License
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Seventh Sense AI